These are exposure studies associated with the disease and all of its children.
|Reference||Associated Study Title||Author's Summary||Study Factors||Stressor||Receptors||Country||Medium||Exposure Marker||Measurements||Outcome|
|1.||Tornhammar P, et al. (2014).||Our objective was to assess the link between season of birth, neonatal 25-hydroxyvitamin D3, and adult cardiovascular disease; we report higher neonatal 25(OH)D3 associated with higher levels of cholesterol (in women), fasting insulin, and triglyceride, and with a higher risk of overweight at 35 years of age, but not with other adult cardiovascular disease risk factors.||sex||Calcifediol | Vitamin D||Infants or newborns | Study subjects||Sweden||blood | serum||Calcifediol | Cholesterol | Insulin | Triglycerides||Details||Obesity | Weight Gain | cholesterol homeostasis | regulation of insulin secretion | triglyceride homeostasis|
|2.||Rantakokko P, et al. (2014).||We observed a trend towards higher weight gain from birth to 3 months of age with increasing placenta tributyltin concentration; however, these results should be interpreted with caution.||Organotin Compounds||Infants or newborns||Finland||placenta||di-n-butyltin | mono-n-butyltin | Organotin Compounds | tributyltin | triphenyltin||Details||Weight Gain|